3 ASX 200 shares worth buying after February’s sell-off

Buy and sell written on a white cube.

February delivered a sharp reality check for ASX investors. A renewed tech-led sell-off dragged several high-quality growth names down toward their 52-week lows, despite little change to their long-term outlooks.

These pullbacks can present rare buying opportunities for the long term.

Here are 3 ASX 200 shares that look increasingly attractive at current levels.

CAR Group Ltd (ASX: CAR)

CAR Group shares are bouncing today, up 7.23% to $26.25. Despite the rebound, the stock remains around 5% lower over the past week following heavy selling earlier this month.

That pullback has pushed CAR Group back toward its 52-week lows, despite a strong first-half performance. As outlined in the company’s FY26 half-year result, CAR Group delivered solid revenue and earnings growth, with management reaffirming its full-year guidance.

From a technical perspective, the chart shows CAR Group recently dipped toward the lower Bollinger Band, a level that often signals short-term exhaustion selling. The relative strength index (RSI) also moved into oversold territory during the wider market sell-off, pointing to market-driven weakness rather than company-specific issues.

CAR Group continues to hold dominant positions across carsales, Trader Interactive, and its global classifieds network. With strong cash generation and clear pricing power, the recent pullback may be giving long-term investors a chance to buy a high-quality business at a more reasonable price.

Xero Ltd (ASX: XRO)

Xero shares have been hit hard in recent sessions. The stock is up 1.17% today to $82.72, but remains almost 12% lower than this time last week.

That decline has taken Xero to levels not seen since early 2023, despite management recently highlighting long-term growth opportunities in artificial intelligence, automation, and the US market.

Technically, Xero looks deeply oversold. The RSI has dropped into the low 20s, historically an area associated with capitulation selling. The price is also hugging the lower Bollinger Band, reinforcing the view that selling pressure may be peaking.

Xero remains a high-quality, recurring revenue software business with strong customer retention. If sentiment stabilises, the current price could prove attractive for long-term investors willing to ride out volatility.

Pro Medicus Ltd (ASX: PME)

Pro Medicus shares are up 1.63% today to $160.20, but the stock is still down about 13% over the past week, putting it near its 52-week low.

This is notable given that Pro Medicus continues to execute exceptionally well operationally. Demand for its Visage imaging platform remains strong, particularly in the US, where contract wins continue to drive long-term earnings visibility.

The recent sell-off appears sentiment-driven, reflecting broader weakness in the technology sector rather than any change to the company’s outlook. The RSI recently slipped into oversold territory, and the price touched the lower end of its trading range, both signals that selling pressure may be easing.

Despite the market correction, Pro Medicus remains one of the highest quality healthcare software businesses on the ASX.

Foolish Takeaway

February’s sell-off has pushed several elite ASX growth stocks back to levels that look appealing.

CAR Group, Xero, and Pro Medicus all retain strong competitive positions and long-term growth drivers. While volatility may persist in the short term, these pullbacks could offer attractive entry points for investors focused on long-term value.

The post 3 ASX 200 shares worth buying after February’s sell-off appeared first on The Motley Fool Australia.

Should you invest $1,000 in CAR Group Ltd right now?

Before you buy CAR Group Ltd shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CAR Group Ltd wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 1 Jan 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended CAR Group Ltd and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.